Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Nov 24 | CHRO Channel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 0.64 | 24,533 | 15.70 k | 634,752 |
14 Jun 24 | CHRO Channel Therapeutics | RSU Common Stock | Grant | Acquire A | No | No | 1.3 | 64,498 | 83.85 k | 610,219 |
21 Feb 24 | CHRO Channel Therapeutics | Common Stock | Buy | Acquire P | No | No | 6 | 16,667 | 100.00 k | 545,721 |
21 Feb 24 | CHRO Channel Therapeutics | Common Stock | Option exercise | Acquire M | Yes | No | 4.8 | 6,992 | 33.56 k | 520,719 |
21 Feb 24 | CHRO Channel Therapeutics | Common Stock | Option exercise | Acquire M | Yes | No | 4.8 | 13,649 | 65.52 k | 513,727 |
21 Feb 24 | CHRO Channel Therapeutics | Secured Convertible Promissory Note Common Stock | Conversion | Dispose C | Yes | No | 4.8 | 33,136 | 159.05 k | 0 |
21 Feb 24 | CHRO Channel Therapeutics | Secured Convertible Promissory Note Common Stock | Conversion | Dispose C | Yes | No | 4.8 | 65,513.61 | 314.47 k | 0 |